Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 22 Neoplasms 13 Colonic Neoplasms 10 Breast Neoplasms 10 Venous Thromboembolism 8 Prostatic Neoplasms 8 Multiple Myeloma 7 Recurrence 6 Polycythemia Vera 6 Carcinoma, Non-Small-Cell Lung 6 Thrombocythemia, Essential 4 Neoplasms, Plasma Cell 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Thrombosis 2 Sarcoma 2 Rectal Neoplasms 2 Primary Myelofibrosis 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Neoplasms by Site 2 Myocardial Infarction 2 Lung Neoplasms 2 Intestinal Neoplasms 2 Intestinal Diseases 2 Inflammation 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2

Interventions

Cisplatin 55 Radiotherapy 33 Cetuximab 25 Paclitaxel 23 Carboplatin 23 Radiotherapy, Intensity-Modulated 21 pembrolizumab 19 Docetaxel 17 Fluorouracil 16 Nivolumab 14 Drug Therapy 11 Radiation 9 Erlotinib Hydrochloride 8 Blood Specimen Collection 8 durvalumab 7 Magnetic Resonance Spectroscopy 7 Surveys and Questionnaires 6 atezolizumab 5 Surgical Procedures, Operative 5 Radiosurgery 5 Esophagectomy 5 Chemoradiotherapy 5 olaparib 4 dacomitinib 4 Leucovorin 4 Cyclophosphamide 4 Capecitabine 4 Biopsy 4 Afatinib 4 fludarabine phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Squamous Cell × Aspirin × Clear all

NCT01496521 2011-12-21

CREAT

Beijing Friendship Hospital

Phase 3 Unknown

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡